Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects

被引：0
|
作者：
Hiroyuki Oshima
Takao Yamazaki
Lauren Benner
Takashi Miki
Ingrid Michon
Tomasz Wojtkowski
Atsunori Kaibara
Salim Mujais
机构：
[1] Astellas Pharma Inc.,
[2] Astellas Pharma Global Development,undefined
[3] Inc.,undefined
[4] Astellas Pharma Global Development,undefined
[5] Inc.,undefined
来源：
Clinical Drug Investigation | 2015年 / 35卷
关键词：
Multiple Dose; Japanese Subject; Caucasian Subject; Fidaxomicin; Japanese Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 384
页数：9
相关论文
共 50 条
  • [31] Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched Caucasian subjects
    Rocha, J. F.
    Falcao, A.
    Lopes, N.
    Santos, A.
    Nunes, T.
    Soares-da-Silva, P.
    JOURNAL OF NEUROLOGY, 2014, 261 : S243 - S243
  • [32] MULTIPLE-DOSE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF APROCITENTAN, A DUAL ENDOTHELIN RECEPTOR ANTAGONIST, IN HEALTHY JAPANESE AND CAUCASIAN SUBJECTS.
    Sidharta, P.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S43 - S44
  • [33] Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects
    Zhuang, Yanli
    Xu, Zhenhua
    de Vries, Dick E.
    Wang, Qingmin
    Shishido, Akira
    Comisar, Craig
    Ford, Joyce A.
    Keen, Monica
    Achira, Meguru
    Tsukamoto, Yuko
    Petty, Kevin J.
    Davis, Hugh M.
    Zhou, Honghui
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 187 - 199
  • [34] PHARMACOKINETICS AND SAFETY OF ABT-981 IN CHINESE, JAPANESE, AND CAUCASIAN HEALTHY SUBJECTS.
    Kosloski, M. P.
    Liu, W.
    Jiang, P.
    Levesque, M. C.
    Medema, J. K.
    Dutta, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S70 - S71
  • [35] A study of the pharmacokinetics and safety of recombinant activated factor VII in healthy Caucasian and Japanese subjects
    Fridberg, MJ
    Hedner, U
    Roberts, HR
    Erhardtsen, E
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (04) : 259 - 266
  • [36] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects
    Yamahira, Naomi
    Frost, Charles
    Fukase, Hiroyuki
    Yu, Zhigang
    Wang, Jessie
    Pursley, Janice
    LaCreta, Frank
    Hiraoka, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (07) : 564 - 573
  • [37] Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects
    Lin, Chih-Wei
    Dutta, Sandeep
    Ding, Bifeng
    Wang, Tianli
    Zadeikis, Neddie
    Asatryan, Armen
    Kort, Jens
    Campbell, Andrew
    Podsadecki, Thomas
    Liu, Wei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (12): : 1616 - 1624
  • [38] Tigecycline Pharmacokinetics, Tolerability, Safety, and Effect on Intestinal Microflora in Healthy Japanese Male Subjects
    Yamashita, Noriaki
    Matschke, Kyle
    Gandhi, Ashesh
    Korth-Bradley, Joan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 513 - 519
  • [39] Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects
    Aoki, Ikuo
    Ishikawa, Kensuke
    Wakana, Akira
    Aso, Masako
    Yoshinori, Tomoko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 170 - 175
  • [40] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF EVINACUMAB, AN ANGIOPOIETIN-LIKE PROTEIN 3 (ANGPTL3) INHIBITOR, IN HEALTHY JAPANESE AND CAUCASIAN SUBJECTS
    Harada-Shiba, M.
    Ali, S.
    Gipe, D. A.
    Gasparino, E.
    Son, V.
    Pordy, R.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2020, 315 : E36 - E37
12345